Literature DB >> 19117988

A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle.

Ezra E W Cohen1, Hongyan Zhu, Mark W Lingen, Leslie E Martin, Wen-Liang Kuo, Eugene A Choi, Masha Kocherginsky, Joel S Parker, Christine H Chung, Marsha Rich Rosner.   

Abstract

Protein kinase Calpha (PKCalpha) has been implicated in cancer, but the mechanism is largely unknown. Here, we show that PKCalpha promotes head and neck squamous cell carcinoma (SCCHN) by a feed-forward network leading to cell cycle deregulation. PKCalpha inhibitors decrease proliferation in SCCHN cell lines and xenografted tumors. PKCalpha inhibition or depletion in tumor cells decreases DNA synthesis by suppressing extracellular signal-regulated kinase phosphorylation and cyclin E synthesis. Additionally, PKCalpha down-regulates miR-15a, a microRNA that directly inhibits protein synthesis of cyclin E, as well as other cell cycle regulators. Furthermore, both PKCalpha and cyclin E protein expression are increased in primary tumors, and PKCalpha inversely correlates with miR-15a expression in primary tumors. Finally, PKCalpha is associated with poor prognosis in SCCHN. These results identify PKCalpha as a key regulator of SCCHN tumor cell growth by a mechanism involving activation of mitogen-activated protein kinase, an initiator of the cell cycle, and suppression of miR-15a, an inhibitor of DNA synthesis. Although the specific components may be different, this type of feed-forward loop network, consisting of a stimulus that activates a positive signal and removes a negative brake, is likely to be a general one that enables induction of DNA synthesis by a variety of growth or oncogenic stimuli.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19117988      PMCID: PMC2746005          DOI: 10.1158/0008-5472.CAN-08-0377

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

1.  Activation of protein kinase C triggers irreversible cell cycle withdrawal in human keratinocytes.

Authors:  Shalini S Tibudan; Yihua Wang; Mitchell F Denning
Journal:  J Invest Dermatol       Date:  2002-12       Impact factor: 8.551

2.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

3.  Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase.

Authors:  H Cai; U Smola; V Wixler; I Eisenmann-Tappe; M T Diaz-Meco; J Moscat; U Rapp; G M Cooper
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

4.  Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes.

Authors:  Jae-Won Soh; I Bernard Weinstein
Journal:  J Biol Chem       Date:  2003-06-06       Impact factor: 5.157

5.  An E2F site in the 5'-promoter region contributes to serum-dependent up-regulation of the human proliferating cell nuclear antigen gene.

Authors:  Yuan-Yuan Li; Lei Wang; Chang-De Lu
Journal:  FEBS Lett       Date:  2003-06-05       Impact factor: 4.124

Review 6.  Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions.

Authors:  Takaaki Hirai; Kazuhiro Chida
Journal:  J Biochem       Date:  2003-01       Impact factor: 3.387

7.  Alterations in murine keratinocyte differentiation induced by activated rasHa genes are mediated by protein kinase C-alpha.

Authors:  A A Dlugosz; C Cheng; E K Williams; A G Dharia; M F Denning; S H Yuspa
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

8.  Differential effects of overexpression of PKC alpha and PKC delta/epsilon on cellular E2F activity in late G1 phase.

Authors:  N Nakaigawa; S Hirai; K Mizuno; T Shuin; M Hosaka; S Ohno
Journal:  Biochem Biophys Res Commun       Date:  1996-05-06       Impact factor: 3.575

9.  Genomic structure and promoter analysis of PKC-delta.

Authors:  Kwang S Suh; Tamara T Tatunchak; John M Crutchley; Lindsay E Edwards; Keith G Marin; Stuart H Yuspa
Journal:  Genomics       Date:  2003-07       Impact factor: 5.736

10.  Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zeta.

Authors:  E Berra; M T Díaz-Meco; J Lozano; S Frutos; M M Municio; P Sánchez; L Sanz; J Moscat
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  41 in total

1.  Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.

Authors:  Wen-Liang Kuo; Jing Liu; Helena Mauceri; Everett E Vokes; Ralph Weichselbaum; Marsha Rich Rosner; Ezra Eddy Wyssam Cohen
Journal:  Mol Cancer Ther       Date:  2010-09-28       Impact factor: 6.261

2.  Preserving biological heterogeneity with a permuted surrogate variable analysis for genomics batch correction.

Authors:  Hilary S Parker; Jeffrey T Leek; Alexander V Favorov; Michael Considine; Xiaoxin Xia; Sameer Chavan; Christine H Chung; Elana J Fertig
Journal:  Bioinformatics       Date:  2014-06-06       Impact factor: 6.937

Review 3.  Outside the coding genome, mammalian microRNAs confer structural and functional complexity.

Authors:  Virginie Olive; Alex C Minella; Lin He
Journal:  Sci Signal       Date:  2015-03-17       Impact factor: 8.192

Review 4.  The microRNA networks of TGFβ signaling in cancer.

Authors:  V P Sivadas; S Kannan
Journal:  Tumour Biol       Date:  2013-12-10

5.  MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.

Authors:  Yulian Mytsyk; Victor Dosenko; Yuriy Borys; Askold Kucher; Katarina Gazdikova; Dietrich Busselberg; Martin Caprnda; Peter Kruzliak; Ammad Ahmad Farooqi; Manyuk Lubov
Journal:  Int Urol Nephrol       Date:  2018-03-16       Impact factor: 2.370

6.  Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors.

Authors:  Jingxiang Huang; Shulin Wu; Chin-Lee Wu; Brendan D Manning
Journal:  Cancer Res       Date:  2009-07-14       Impact factor: 12.701

7.  A novel microRNA and transcription factor mediated regulatory network in schizophrenia.

Authors:  An-Yuan Guo; Jingchun Sun; Peilin Jia; Zhongming Zhao
Journal:  BMC Syst Biol       Date:  2010-02-15

Review 8.  Coupling transcriptional and post-transcriptional miRNA regulation in the control of cell fate.

Authors:  Reut Shalgi; Ran Brosh; Moshe Oren; Yitzhak Pilpel; Varda Rotter
Journal:  Aging (Albany NY)       Date:  2009-09-08       Impact factor: 5.682

9.  Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axis.

Authors:  Daisuke Hoshino; Jerome Jourquin; Shane Weller Emmons; Tyne Miller; Margalit Goldgof; Kaitlin Costello; Darren R Tyson; Brandee Brown; Yiling Lu; Nagendra K Prasad; Bing Zhang; Gordon B Mills; Wendell G Yarbrough; Vito Quaranta; Motoharu Seiki; Alissa M Weaver
Journal:  Sci Signal       Date:  2012-09-11       Impact factor: 8.192

Review 10.  PKC signaling in glioblastoma.

Authors:  Anália do Carmo; Joana Balça-Silva; Diana Matias; Maria Celeste Lopes
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.